jco article insights: atezolizumab plus bevacizumab, chemotherapy in egfr, alk nsclc
Published 6 months ago • 54 plays • Length 12:06Download video MP4
Download video MP3
Similar videos
-
6:51
jco po article insights: talazoparib in solid tumors with brca1/2 mutation
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
3:11
impower150: atezolizumab, chemotherapy and bevacizumab for nsclc
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
1:31
impower150: efficacy outcomes of atezolizumab addition in pre-treated egfr-mutated nsclc
-
45:34
demystifying energy medicine with jill blakeway | the goop podcast
-
36:01
podcast: new hope for pancreatic cancer patients | osuccc – james
-
29:52
s1 episode 3: immunotherapy and lung cancer treatment
-
3:54
guadecitabine atezolizumab in muc who have progressed after initial checkpoint inhibitor therapy
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
1:06
fort 05-beat: comparing 1l atezolizumab vs atezolizumab bevacizumab in pd-l1 high nsclc
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
4:03
atezolizumab injection explained: uses, dosage, mechanism, side effects & advice | mediinsights
-
1:41
adjuvant atezolizumab in nsclc
-
0:40
beat-meso: phase iii trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma
-
0:54
sb8: a bevacizumab biosimilar for nsclc
-
5:12
safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
-
0:32
will atezolizumab and bevacizumab be the new soc in high-risk hcc?
-
2:12
real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic uc